These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 19800245)
1. Semisynthetic latrunculin B analogs: studies of actin docking support a proposed mechanism for latrunculin bioactivity. Kudrimoti S; Ahmed SA; Daga PR; Wahba AE; Khalifa SI; Doerksen RJ; Hamann MT Bioorg Med Chem; 2009 Nov; 17(21):7517-22. PubMed ID: 19800245 [TBL] [Abstract][Full Text] [Related]
2. Latrunculin with a highly oxidized thiazolidinone ring: structure assignment and actin docking. Ahmed SA; Odde S; Daga PR; Bowling JJ; Mesbah MK; Youssef DT; Khalifa SI; Doerksen RJ; Hamann MT Org Lett; 2007 Nov; 9(23):4773-6. PubMed ID: 17929935 [TBL] [Abstract][Full Text] [Related]
3. Semisynthetic latrunculin derivatives as inhibitors of metastatic breast cancer: biological evaluations, preliminary structure-activity relationship and molecular modeling studies. Khanfar MA; Youssef DT; El Sayed KA ChemMedChem; 2010 Feb; 5(2):274-85. PubMed ID: 20043312 [TBL] [Abstract][Full Text] [Related]
4. Bioactive natural and semisynthetic latrunculins. El Sayed KA; Youssef DT; Marchetti D J Nat Prod; 2006 Feb; 69(2):219-23. PubMed ID: 16499319 [TBL] [Abstract][Full Text] [Related]
5. Differential binding of latrunculins to G-actin: a molecular dynamics study. Helal MA; Khalifa S; Ahmed S J Chem Inf Model; 2013 Sep; 53(9):2369-75. PubMed ID: 23988111 [TBL] [Abstract][Full Text] [Related]
6. Total syntheses of the actin-binding macrolides latrunculin A, B, C, M, S and 16-epi-latrunculin B. Fürstner A; De Souza D; Turet L; Fenster MD; Parra-Rapado L; Wirtz C; Mynott R; Lehmann CW Chemistry; 2007; 13(1):115-34. PubMed ID: 17091520 [TBL] [Abstract][Full Text] [Related]
7. A new dimension to the biosynthetic products isolated from the sponge Negombata magnifica. Vilozny B; Amagata T; Mooberry SL; Crews P J Nat Prod; 2004 Jun; 67(6):1055-7. PubMed ID: 15217296 [TBL] [Abstract][Full Text] [Related]
8. Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells. Sayed KA; Khanfar MA; Shallal HM; Muralidharan A; Awate B; Youssef DT; Liu Y; Zhou YD; Nagle DG; Shah G J Nat Prod; 2008 Mar; 71(3):396-402. PubMed ID: 18298079 [TBL] [Abstract][Full Text] [Related]
9. Quantitative determination of latrunculins A and B in the Red Sea sponge Negombata magnifica by high performance liquid chromatography. Khalifa S; Ahmed S; Mesbah M; Youssef D; Hamann M J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 832(1):47-51. PubMed ID: 16431167 [TBL] [Abstract][Full Text] [Related]
10. Latrunculin analogues with improved biological profiles by "diverted total synthesis": preparation, evaluation, and computational analysis. Fürstner A; Kirk D; Fenster MD; Aïssa C; De Souza D; Nevado C; Tuttle T; Thiel W; Müller O Chemistry; 2007; 13(1):135-49. PubMed ID: 17091521 [TBL] [Abstract][Full Text] [Related]
11. Total synthesis of (+)-18-epi-latrunculol A: development of a synthetic route. Williams BD; Smith AB J Org Chem; 2014 Oct; 79(19):9284-96. PubMed ID: 25243951 [TBL] [Abstract][Full Text] [Related]
14. Truncated Latrunculins as Actin Inhibitors Targeting Plasmodium falciparum Motility and Host Cell Invasion. Johnson S; Rahmani R; Drew DR; Williams MJ; Wilkinson M; Tan YH; Huang JX; Tonkin CJ; Beeson JG; Baum J; Smith BJ; Baell JB J Med Chem; 2016 Dec; 59(24):10994-11005. PubMed ID: 28002959 [TBL] [Abstract][Full Text] [Related]
15. Molecular Dynamics Simulation Reveal the Mechanism of Resistance of Mutant Actins to Latrunculin A - Insight into Specific Modifications to Design Novel Drugs to Overcome Resistance. Lalitha R; R PK; Mohammed MM Curr Comput Aided Drug Des; 2016; 12(2):107-18. PubMed ID: 27484118 [TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR studies of latrunculin-based actin polymerization inhibitors using CoMFA and CoMSIA approaches. Khanfar MA; Youssef DT; El Sayed KA Eur J Med Chem; 2010 Sep; 45(9):3662-8. PubMed ID: 20684858 [TBL] [Abstract][Full Text] [Related]
17. Latrunculins--novel marine macrolides that disrupt microfilament organization and affect cell growth: I. Comparison with cytochalasin D. Spector I; Shochet NR; Blasberger D; Kashman Y Cell Motil Cytoskeleton; 1989; 13(3):127-44. PubMed ID: 2776221 [TBL] [Abstract][Full Text] [Related]
18. Toward computing relative configurations: 16-epi-latrunculin B, a new stereoisomer of the actin polymerization inhibitor latrunculin B. Hoye TR; Ayyad SE; Eklov BM; Hashish NE; Shier WT; El-Sayed KA; Hamann MT J Am Chem Soc; 2002 Jun; 124(25):7405-10. PubMed ID: 12071749 [TBL] [Abstract][Full Text] [Related]
19. Diverted total synthesis: preparation of a focused library of latrunculin analogues and evaluation of their actin-binding properties. Fürstner A; Kirk D; Fenster MD; Aïssa C; De Souza D; Müller O Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8103-8. PubMed ID: 15917332 [TBL] [Abstract][Full Text] [Related]
20. Actin-latrunculin A structure and function. Differential modulation of actin-binding protein function by latrunculin A. Yarmola EG; Somasundaram T; Boring TA; Spector I; Bubb MR J Biol Chem; 2000 Sep; 275(36):28120-7. PubMed ID: 10859320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]